昭衍新药已回购210万股 累计回购金额3320万元

财中社
02 Dec 2024

财中社12月2日电昭衍新药(603127/06127)发布关于以集中竞价交易方式回购公司A股股份的进展公告。根据公告,公司自2024年3月29日首次披露回购方案以来,回购金额预计在5000万元至1亿元之间。回购的股份将用于员工持股计划或股权激励。截至2024年11月30日,公司累计已回购股数为210万股,占总股本的0.2806%,累计回购金额为3320万元,回购价格区间在13.2元/股至18.15...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10